ByTrending Posts
How Did Johnson & Johnson Navigate 2025 and…
Johnson & Johnson concluded 2025 with a combination of resilient portfolio performance, strategic execution, and ongoing innovation across…
How Did Novartis’ 2025 Deals Shape Its Strategic…
Novartis’ deal activity in 2025 reflected a deliberate and strategic effort to strengthen its scientific platforms, broaden its…
How Did Novartis Navigate 2025 and What’s Ahead…
In 2025, Novartis demonstrated resilience and strategic focus, balancing strong performance in its core franchises with investments in…
How Did AbbVie’s 2025 Deals Shape Its Year,…
NORTH CHICAGO, IL — As 2025 concludes, AbbVie Inc. reflects on a year of strategic dealmaking that complements…
Did AbbVie Successfully Manage 2025 Headwinds, and Are…
NORTH CHICAGO, ILLINOIS — As 2025 comes to a close, AbbVie reflects on a year marked by strong…
Is Lilly Shaping Its Post-Blockbuster Future Through Verve,…
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster brands driving growth…
Is Lilly Strengthening Its 2026 Growth Outlook by…
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a focused strategy centered…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping…
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at strengthening its pipeline,…
Can Pfizer’s 2025 Execution Set the Stage for…
NEW YORK, NY — As 2025 comes to a close, Pfizer Inc. reflects on a year marked by…
Trending Posts
Latest Stories
Will Roche’s 2025 Earnings Reset the Narrative for 2026 Growth and Pipeline Confidence?
January 29, 2026 | Full-Year Earnings | Big Pharma Outlook Roche is set to publish…
Why Is Roche Returning to China for Its Next Antibody-Drug Conjugate Bet?
January 2026 – Strategic Partnerships | China Biopharma | Oncology & ADCs Roche has extended…
Roche Signals Dual Growth Strategy: Price Reform Alignment in the U.S. and Aggressive Expansion Across Oncology and Obesity
January 2026 | Pharma & Policy | Bloomberg Interview Insight Roche is positioning itself for…
Can Amgen’s Strategic Partnerships Redefine Access and Growth in the GLP‑1 Market?
23 January 2026 Executive Summary Amgen is actively exploring strategic collaborations with telehealth platforms and…
Gallery
